MESA Labs (MLAB) Director Mark Capone Receives RSU Award

What Happened Mark Christopher Capone, a director of Mesa Laboratories, was granted 2,423 restricted stock units (RSUs) on September 9, 2026. The award is reported as a derivative acquisition with an acquisition price of $0 (total reported value $0). This was an award/grant (not an open‑market purchase or sale).

Key Details

• Transaction date: September 9, 2026; Form 4 filed September 11, 2026 (two days after the grant).
• Transaction type/code: Award/Grant (A); 2,423 RSUs @ $0 reported.
• Vesting: RSUs vest on September 9, 2027 (per filing footnote).
• Shares owned after transaction: Not specified in the filing.
• Footnotes: F1—each RSU converts to one share upon vesting; F2—vest date Sept 9, 2027; F3—Not applicable.
• Timeliness: Filing appears timely (filed two days after the grant).

Context RSUs are a form of equity compensation that give the holder a contingent right to receive shares once vesting conditions are met; they do not require an immediate cash outlay and are not an immediate purchase of stock. Grants like this are common for directors and reflect compensation, not a direct buy or sell signal.